N/A N=6 Pathologic and Immunologic Response After Ablative Radiation in Lung Cancer
Non-small Cell Lung Cancer Stage I
Primary: Examine the T-cell Receptor Profile Changes Induced in the Tumor After SABR
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=101 Investigation to Optimize Hemodynamic Management of Left Ventricular Assist Devices Using the CardioMEMS™
Heart Failure
Primary: Six Minute Hall Walk (6MHW) Distance — -44.9; 69.7 meters — p=0.001
N/A N=36 Nicotine Pharmacokinetics Following Use of the P4M3 Gen 2.0 E-Cigarette Compared to Smoking Cigarettes
Nicotine Vaping · Nicotine · Vaping
Primary: Background-corrected Maximum Plasma Concentration [Cmax] — 2.934; 3.365; 17.49 (ng/mL)
N/A N=126 Improving Weight Loss Outcomes for Binge Eating Disorder.
Eating Disorder · Binge-Eating Disorder · Weight Loss
Primary: Weight Loss — 0; 0; -2.13; -2.15 percentage of weight loss
N/A N=556 Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
Coronary Artery Disease · Atherosclerosis, Coronary · Myocardial Ischemia
Primary: Percentage of Participants With Target Lesion Failure (TLF) at 12 Months Post-Index Procedure — 9 Participants — p=<0.0001
N/A N=52 Sonu Nasal Congestion Relief Study in Patients Suffering From Moderate to Severe Nasal Congestion
Nasal Congestion and Inflammations
Primary: Primary Effectiveness — -0.87; -0.44 score on a scale
N/A N=15 Clinical Study to Evaluate the 80-Minute Water Resistant Sun Protection Factor (SPF) of Sunscreen Products
Sunscreening Agents
Primary: Arithmetic Mean SPF Values
Phase 4 N=200 A Study to Describe the Safety of a Vaccine (Called 13vPnC) in Healthy People 18 to 49 Years of Age in India
Pneumococcal Disease
Primary: Percentage of Participants With Prompted Local Reactions Within 7 Days After Vaccination — 1.5; 6.5; 63.0 Percentage
N/A N=300 Sylvatic Transmission of Zika, Dengue, and Chikungunya Viruses in Thailand and Cambodia
Dengue Fever · Zika · Vector-Borne Diseases
Primary: Assessment of DENV, ZIKV, CHIKV Seroprevalence Via Screening PRNT50 Titers in Cambodian Adults. — 300 Participants
Phase 1 N=29 Crossover Study to Assess the Relative Bioavailability and Bioequivalence of Niraparib Tablet Compared to Niraparib Capsule
Neoplasms
Primary: Area Under the Concentration-time Curve From Time 0 to the Time of the Last Quantifiable Concentration (AUC[0-t]) for Niraparib-Stage 1 PK Phase — 14900; 16100…
Phase 4 N=62 A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye Disease
Thyroid Eye Disease · Chronic (Inactive) Thyroid Eye Disease
Primary: Change From Baseline in Proptosis of Study Eye at Week 24 — -2.41; -0.92 Millimieter (mm) — p=0.0004
N/A N=212 Guidance of Ultrasound in Intensive Care to Direct Euvolemia
Acute Kidney Injury
Primary: Number of Acute Kidney Injury (AKI)-Free Days — 1; 1 Days
N/A N=55 Efficacy of Reinforcing Standard Therapy in COVID-19 Patients With Repeated Transfusion of Convalescent Plasma
Covid19
Primary: Adaptive COVID-19 Treatment Trial Scale (ACTT) Version II — 0; 0; 0; 0 Participants
N/A N=54 Additional Long-Term Follow-up for Subjects Implanted With a CyPass® Micro-Stent
Primary Open Angle Glaucoma · Cataract
Primary: Percentage of Eyes With Sight-threatening Adverse Events (AEs) — 18.5; 0.0; 0.0; 0.0 percentage of eyes
N/A N=30 Quit or Switch: E-cigarette Study
Tobacco Use
Primary: Percentage of Participants Who Report Daily Use of E-cigarettes or NRT and no Cigarette Use